Record

RefNoEC/2016/01
LevelItem
TitleAbell, Christopher: certificate of election to the Royal Society
Date28 April 2016
DescriptionCitation typed
CitationChris Abell has made several fundamental contributions to biological chemistry, including pioneering detection of covalent intermediates on enzymes by mass spectrometry, and providing the first structural evidence for an ester linkage in a protein backbone. He has used his unique scientific insight and technological innovation to co-found several companies, most notably Astex (1999), Sphere Fluidics (2010) and Aqdot (2013). Using Fragment-Based Drug Discovery (FBDD), Astex has already developed 8 drug candidates that are now in human trials. FBDD has been adopted by almost every major pharmaceutical company in the world, literally changing the way drugs are discovered
Extent4p
FormatPrinted
AccessStatusClosed
Add to My Items

    Collection highlights

    Browse the records of some of our collections, which cover all branches of science and date from the 12th century onwards. These include the published works of Fellows of the Royal Society, personal papers of eminent scientists, letters and manuscripts sent to the Society or presented at meetings, and administrative records documenting the Society's activities since our foundation in 1660.

    The Royal Society

    The Royal Society is a Fellowship of many of
    the world's most eminent scientists and is the
    oldest scientific academy in continuous existence.
    Registered charity number 207043

    Website design ©CalmView



    CONTACT US

    + 44 207 451 2500
    (Lines open Mon-Fri, 9:00-17:00. Excludes bank holidays)

    6-9 Carlton House Terrace, London SW1Y 5AG

    Email Us →

    SUBSCRIBE

    Subscribe to our newsletters to be updated with the
    latest news on innovation, events, articles and reports.

    Subscribe →

    © CalmView